We are live on ! Find out more
PFO

Pathstone Family Office Portfolio holdings

AUM $13.1B
1-Year Est. Return 21.02%
This Fund
S&P 500
This Quarter Est. Return
+0.72%
1 Year Est. Return
+21.02%
3 Year Est. Return
+39.27%
5 Year Est. Return
+59.47%
10 Year Est. Return
+236.85%
AUM
$768M
AUM Growth
-$80.1M
Cap. Flow
-$27.1M
Cap. Flow %
-3.53%
Top 10 Hldgs %
60.99%
Holding
740
New
85
Increased
91
Reduced
143
Closed
103

Top Buys

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$1.75M
2
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
+$1.16M
3
LYFT icon
Lyft
LYFT
+$989K
4
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$721K
5
XYL icon
Xylem
XYL
+$522K

Top Sells

Rank Stock Value
1
RY icon
Royal Bank of Canada
RY
+$11.3M
2
IWB icon
iShares Russell 1000 ETF
IWB
+$9.09M
3
KMX icon
CarMax
KMX
+$5.75M
4
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$2.77M
5
MSFT icon
Microsoft
MSFT
+$2.09M

Sector Composition

Rank Sector Weight
1 Financials 25.36%
2 Technology 10.73%
3 Consumer Discretionary 9.26%
4 Communication Services 3.87%
5 Industrials 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ROSE
576
DELISTED
Rosehill Resources Inc. Class A
ROSE
$2K ﹤0.01%
+1,006
New +$2.29K
CFRX
577
DELISTED
ContraFect Corporation
CFRX
$2K ﹤0.01%
6
– –
ALL icon
578
Allstate
ALL
$68B
$1K ﹤0.01%
7
– –
BKR icon
579
Baker Hughes
BKR
$60.8B
$1K ﹤0.01%
37
– –
C icon
580
Citigroup
C
$231B
$1K ﹤0.01%
18
-85
-83% -$5.78K
COP icon
581
ConocoPhillips
COP
$140B
$1K ﹤0.01%
20
-720
-97% -$41K
FHLC icon
582
Fidelity MSCI Health Care Index ETF
FHLC
$3.31B
$1K ﹤0.01%
34
-1
-3% -$44
FTEC icon
583
Fidelity MSCI Information Technology Index ETF
FTEC
$21.1B
$1K ﹤0.01%
15
– –
HAS icon
584
Hasbro
HAS
$12.9B
$1K ﹤0.01%
5
– –
HII icon
585
Huntington Ingalls Industries
HII
$12.6B
$1K ﹤0.01%
5
– –
HON icon
586
Honeywell
HON
$78.6B
$1K ﹤0.01%
4
-4,456
-100% -$709K
HYI
587
Western Asset High Yield Opportunity Fund Inc
HYI
$135M
$1K ﹤0.01%
+36
New +$547
KEYS icon
588
Keysight
KEYS
$58B
$1K ﹤0.01%
8
– –
LITE icon
589
Lumentum
LITE
$65.9B
$1K ﹤0.01%
11
– –
MJ icon
590
Amplify Alternative Harvest ETF
MJ
$100M
$1K ﹤0.01%
4
– –
NBR icon
591
Nabors Industries
NBR
$1.18B
$1K ﹤0.01%
11
– –
NMFC icon
592
New Mountain Finance
NMFC
$692M
$1K ﹤0.01%
+77
New +$1.05K
PTCT icon
593
PTC Therapeutics
PTCT
$5.77B
$1K ﹤0.01%
+28
New +$1.22K
RBBN icon
594
Ribbon Communications
RBBN
$372M
$1K ﹤0.01%
200
– –
RIG icon
595
Transocean
RIG
$5.69B
$1K ﹤0.01%
128
– –
TAP icon
596
Molson Coors Class B
TAP
$7.85B
$1K ﹤0.01%
15
– –
TDS icon
597
Telephone and Data Systems
TDS
$4.01B
$1K ﹤0.01%
39
– –
UBS icon
598
UBS Group
UBS
$176B
$1K ﹤0.01%
48
– –
VIAV icon
599
Viavi Solutions
VIAV
$9.8B
$1K ﹤0.01%
56
– –
XRX icon
600
Xerox
XRX
$411M
$1K ﹤0.01%
+32
New +$1K
22 23
24
25 26

Similar funds

CG
Colony Group Boston, Massachusetts $6.66B AUM 18.65% 1-Year Est. Return
API
Advisor Partners II Walnut Creek, California $2.49B AUM 30.88% 1-Year Est. Return
TA
Tiedemann Advisors New York $2.33B AUM 15.56% 1-Year Est. Return
SCH
Sylebra Capital (HK) Hong Kong $1.88B AUM 19.75% 1-Year Est. Return
PWAG
Polaris Wealth Advisory Group San Rafael, California $1.31B AUM 17.95% 1-Year Est. Return
CS
Comerica Securities Detroit, Michigan $1.2B AUM 16.58% 1-Year Est. Return
IWP
Icon Wealth Partners Houston, Texas $880M AUM
MAM
Mastrapasqua Asset Management Nashville, Tennessee $853M AUM 37.36% 1-Year Est. Return

Pathstone Family Office's Q3 2019 Portfolio in Review

As of Q3 2019, Pathstone Family Office held 740 positions worth $768M, down 9.5% from $848M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Pathstone Family Office withdrew a net $27.1M in Q3 2019, closing 103 positions and reducing 143 holdings. Its most notable exit was UroGen Pharma, an estimated $1.47M position sold in full.

By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 25% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Pathstone Family Office opened a new position in Xylem worth $529K.

  • Pathstone Family Office's largest Q3 2019 buy was Xylem: 6,643 shares worth $529K.
  • Pathstone Family Office added most to Vanguard S&P 500 ETF in Q3 2019, an estimated $1.75M increase.
  • Pathstone Family Office's biggest Q3 2019 reduction was Royal Bank of Canada, cutting an estimated $11.3M.
  • Pathstone Family Office fully exited UroGen Pharma in Q3 2019, selling an estimated $1.47M.
  • Pathstone Family Office's ten largest holdings make up 61% of its $768M portfolio in Q3 2019.
  • Pathstone Family Office opened 85 new positions and closed 103 in Q3 2019.
  • Pathstone Family Office's portfolio value fell 9.5% quarter-over-quarter to $768M.

Based on Pathstone Family Office's 13F filing for Q3 2019, filed 13 Nov 2019.